CVI Holdings’s Orphazyme A/S ORPH Stock Holding History

CVI Holdings’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-175,000	Closed	-$1.81M	–	207
2020 Q3	$1.81M	Buy	+175,000	New	+$1.75M	0.73%	36

Other funds holding ORPH

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CVI Holdings's ORPH Position: Q4 2020 in Review

CVI Holdings sold out of Orphazyme A/S (ORPH) in Q4 2020, closing a stake of 175,000 shares — an estimated $1.81M sold.

CVI Holdings first reported a position in ORPH in Q3 2020 and held it in 1 quarter. The position peaked at $1.81M in Q3 2020. 5 funds tracked by Wall St. Rank hold ORPH as of Q4 2020.

CVI Holdings reported no remaining Orphazyme A/S position as of Q4 2020 after selling out during the quarter.
CVI Holdings sold 175,000 Orphazyme A/S shares in Q4 2020, an estimated $1.81M.
CVI Holdings first reported a position in Orphazyme A/S in Q3 2020 and held it in 1 quarter.
CVI Holdings's Orphazyme A/S position peaked at $1.81M in Q3 2020.
5 funds tracked by Wall St. Rank held Orphazyme A/S as of Q4 2020.

Based on CVI Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.